Vetsys Pharmaceutical
Vetsys Pharmaceutical
Finland represents one of the most sophisticated dairy markets in the European Union. With a focus on animal welfare and high-quality milk production (Valio standards), Finnish farmers and veterinarians demand intramammary infusions that are not only effective but also comply with strict Fimea (Finnish Medicines Agency) and EU regulations. Mastitis remains the most significant economic challenge for Finland's dairy sector, which comprises approximately 5,000 active farms across regions like Ostrobothnia and Savo.
Finland is a pioneer in the "target-led" use of antibiotics. Unlike many other regions, Finnish veterinary protocols emphasize precise diagnosis before treatment. This is where Zhengzhou Vetsys Pharmaceutical Co., Ltd. steps in as a critical supplier. Our range of Cefquinome and Ampicillin-based infusions are designed to integrate seamlessly into Finnish precision farming systems, supporting the goal of minimizing antibiotic resistance while ensuring maximum cure rates.
Recent data indicates a shift toward "Dry Cow Therapy" (DCT) optimization and the use of combination therapies like Ampicillin and Cloxacillin. In Finland’s cold climate, housing conditions during the winter months increase the risk of environmental mastitis. Reliable intramammary infusions are essential for maintaining herd health during these high-risk periods. As a leading manufacturer, we provide formulations that maintain stability and efficacy even in variable storage temperatures, meeting the needs of Northern European distribution.
Established Year
Certification Standard
Annual Sales
Independent R&D
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a powerhouse in the animal pharmaceutical industry. With a registered capital of 30 million RMB and a legacy dating back to 2005, we have evolved from a domestic leader in China to a global supplier serving high-requirement markets like Finland. Our facility is a marvel of modern AI-integrated manufacturing, housing specialized workshops for powders, injections, and oral solutions.
What sets Vetsys apart in the Finnish market is our Independent Research Institute. Equipped with five specialized laboratories and a team of world-class scientists, we don't just manufacture; we innovate. This allows us to customize intramammary infusion viscosity and syringe delivery systems specifically for the ergonomic and environmental needs of Finnish veterinary practitioners.
Quality is the cornerstone of our operations. We adhere to rigorous Good Manufacturing Practices (GMP) and ISO standards. Every batch of Cefquinome Sulfate or Florfenicol Infusion undergoes extensive quality control checks. For our Finnish partners, this means a reliable supply chain and consistent efficacy, ensuring that every cow treated has the best chance of returning to the production line quickly and safely.
At Vetsys, we recognize that the future of animal healthcare in Finland and beyond is intrinsically linked to sustainability. Our "Green Pharma" initiative focuses on reducing the carbon footprint of our manufacturing processes and ensuring that our drug delivery systems—like our intramammary syringes—are increasingly made from recyclable or biodegradable materials.
As we expand our presence in the Nordic region, we are looking for strategic partnerships with Finnish agricultural distributors and veterinary clinics. Our vision is to combine Chinese manufacturing efficiency with Finnish standards of excellence. Whether it's Compound Amoxicillin or Gentamycin formulations, our commitment remains the same: improving animal health through continuous innovation, world-class quality, and sustainable practices.
